• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
95.92 -0.05
(-0.05%)
EUR-INR
108.79 -0.10
(-0.09%)
GBP-INR
127.19 0.21
(0.17%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Rishiroop Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
526492
INE582D01013
149.5927999
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
10.22
109.51
EPS(TTM)
Face Value()
Div & Yield %
11.69
10
1.25
 

pakka ltd
Beryl Drugs standalone net profit rises 273.33% in the March 2026 quarter
May 29,2026
Net profit of Beryl Drugs rose 273.33% to Rs 0.56 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 29.22% to Rs 5.13 crore in the quarter ended March 2026 as against Rs 3.97 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.59% to Rs 0.42 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales declined 11.02% to Rs 18.82 crore in the year ended March 2026 as against Rs 21.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales5.133.97 29 18.8221.15 -11
OPM %25.9312.59 -12.8112.53 -
PBDT1.260.42 200 2.072.12 -2
PBT0.860.10 760 0.580.87 -33
NP0.560.15 273 0.420.58 -28